Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.21% | 44.71% | 0.31% | -46.02% | -48.55% |
| Total Depreciation and Amortization | -3.06% | -31.37% | -29.13% | -20.09% | -3.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,076.36% | -308.07% | 55.10% | 118.63% | -- |
| Change in Net Operating Assets | -32.72% | -179.21% | 242.96% | 925.31% | -6.50% |
| Cash from Operations | 37.00% | -70.93% | 28.77% | -34.93% | -81.01% |
| Capital Expenditure | -- | -- | -- | 167.20% | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -32.57% | 41.95% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Investing | -100.00% | -32.57% | 41.95% | 574.33% | -- |
| Total Debt Issued | -17.73% | 102.02% | -10.99% | 15.10% | 38.47% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -74.21% | -62.48% | 182.24% | -- |
| Cash from Financing | -39.63% | 51.74% | -20.58% | 30.63% | 88.70% |
| Foreign Exchange rate Adjustments | 97.01% | 93.10% | -53.00% | -518.80% | -911.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.86% | 3.57% | -130.26% | -275.46% | 105.93% |